STOCK TITAN
  1. Home
  2. Sec-filings
  3. CVRX
  4. [Form 4] CVRx, Inc. Insider Trading Activity

CVRx, Inc. (CVRX) director granted shares and stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

A director of CVRx, Inc. received equity awards consisting of 29,005 shares of Common Stock and stock options covering 36,252 shares on June 1, 2026 as compensation.

The options have an exercise price of $5.43 per share, are exercisable for 36,252 shares of Common Stock, and expire on June 1, 2036. According to the vesting terms, one-third of the shares subject to these awards vest on each annual anniversary of the grant date. Following these awards, the director directly holds 29,005 shares of Common Stock and options on 36,252 shares.

Positive

  • None.

Negative

  • None.
Insider DALE MICHAEL D
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 36,252 $0.00 --
Grant/Award Common Stock 29,005 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 36,252 shares (Direct, null); Common Stock — 29,005 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Common Stock award 29,005 shares Shares of Common Stock granted to director on June 1, 2026
Stock options granted 36,252 options Options on Common Stock granted on June 1, 2026
Option exercise price $5.43 per share Conversion or exercise price for 36,252 stock options
Option expiration June 1, 2036 Expiration date of granted stock options
Shares held after grant 29,005 shares Total Common Stock directly owned following the award
Options held after grant 36,252 options Total options directly owned following the award
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of $5.43 per share"
Common Stock financial
"29,005 shares of Common Stock were granted as an equity award"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
grant/award acquisition financial
"The transaction code A reflects a grant/award acquisition of equity"
vests financial
"Vests as to one-third of the shares on each annual anniversary of the date of grant"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DALE MICHAEL D
(Last)(First)(Middle)
9201 WEST BROADWAY AVENUE
SUITE 650
(Street)
MINNEAPOLIS MINNESOTA 55445
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/01/2026A29,005(1)A$029,005D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$5.4306/01/2026A36,252 (1)06/01/2036Common Stock36,252$036,252D
Explanation of Responses:
1. Vests as to one-third of the shares on each annual anniversary of the date of grant.
/s/ Amy C. Seidel, Attorney-in-Fact06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did the CVRX director acquire in this Form 4 filing?

The director received 29,005 shares of CVRx, Inc. Common Stock and stock options for 36,252 shares. These equity awards were granted as compensation and increase the director’s direct ownership and future potential stake in the company’s common stock.

What is the exercise price of the CVRX director’s new stock options?

The granted stock options have an exercise price of $5.43 per share. This means the director can later buy up to 36,252 CVRx Common shares at $5.43 each, regardless of the future market price, once the options are vested and exercised.

When do the newly granted CVRX stock options expire?

The director’s stock options expire on June 1, 2036. If the options are not exercised by that date, they will lapse. This expiration date defines the maximum period during which the director can choose to exercise these options for Common Stock.

How do the CVRX director’s equity awards vest over time?

The awards vest in three equal parts, with one-third of the shares vesting on each annual anniversary of the grant date. This applies to the underlying shares, aligning the director’s ownership incentives with longer-term company performance over several years.

How many CVRX shares does the director hold after these transactions?

After these transactions, the director directly holds 29,005 shares of CVRx Common Stock and options covering 36,252 additional shares. This reflects the position immediately following the equity grants reported in this Form 4 insider transaction filing.